Experienced in Alzheimer's Disease

Dr. Judith F. Joseph

Psychiatry
56 Hamilton St, 
Paterson, NJ 
Experienced in Alzheimer's Disease
56 Hamilton St, 
Paterson, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Judith Joseph is a Psychiatrist in Paterson, New Jersey. Dr. Joseph is rated as an Experienced provider by MediFind in the treatment of Alzheimer's Disease. Her top areas of expertise are Alzheimer's Disease and Dementia.

Her clinical research consists of co-authoring 2 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 5 clinical trials in the study of Alzheimer's Disease.

Specialties
Psychiatry
Licenses
Psychiatry & Neurology in NY
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

56 Hamilton St, Paterson, NJ 07505

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder
A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder
Enrollment Status: Completed
Publish Date: May 29, 2025
Intervention Type: Drug
Study Drug: BTRX-335140
Study Phase: Phase 2
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: ATH-1017
Study Phase: Phase 2/Phase 3
A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease
A Randomized , Double Blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients With Early Stage Alzheimer's Disease
Enrollment Status: Completed
Publish Date: February 18, 2025
Intervention Type: Drug
Study Drug: BPN14770
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Three Dose Strengths of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Three Dose Strengths of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: July 19, 2024
Intervention Type: Drug
Study Drug: T3D-959
Study Phase: Phase 2
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled Proof-of-Concept Study of a Selective p38 MAP Kinase Alpha Inhibitor, Neflamapimod, Administered for 24 Weeks in Subjects With Mild Alzheimer's Disease
A Double-Blind, Placebo-Controlled Proof-of-Concept Study of a Selective p38 MAP Kinase Alpha Inhibitor, Neflamapimod, Administered for 24 Weeks in Subjects With Mild Alzheimer's Disease
Enrollment Status: Completed
Publish Date: October 27, 2021
Intervention Type: Drug, Other
Study Phase: Phase 2
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
Enrollment Status: Terminated
Publish Date: September 05, 2021
Intervention Type: Combination product
Study Drug: ABILIFY MYCITE
Study Phase: Phase 3
View 7 Less Clinical Trials

2 Total Publications

A Phase 2, multicenter, double-blind, randomized, placebo-controlled study of the safety and efficacy of forvisirvat (SP-624) in the treatment of adults with major depressive disorder.
A Phase 2, multicenter, double-blind, randomized, placebo-controlled study of the safety and efficacy of forvisirvat (SP-624) in the treatment of adults with major depressive disorder.
Journal: Current medical research and opinion
Published: October 16, 2025
Similar Doctors
Wei E. Wang
Distinguished in Alzheimer's Disease
Dr. Wei E. Wang
Psychiatry
Distinguished in Alzheimer's Disease
Dr. Wei E. Wang
Psychiatry
35 W Hudson Ave, 
Englewood, NJ 
 (10.6 miles away)
201-408-4487
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients

Wei Wang is a Psychiatrist in Englewood, New Jersey. Dr. Wang is rated as an Elite provider by MediFind in the treatment of Alzheimer's Disease. Her top areas of expertise are Gallbladder Disease, Dementia, Ocular Hypertension (OHT), Endoscopy, and Bone Marrow Aspiration. Dr. Wang is currently accepting new patients.

Distinguished in Alzheimer's Disease
Dr. William T. Hu
Psychiatry | Neurology
Distinguished in Alzheimer's Disease
Dr. William T. Hu
Psychiatry | Neurology
125 Paterson St Ste 6100, 
New Brunswick, NJ 
 (33.0 miles away)
732-235-7340
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Hu is a Psychiatrist and a Neurologist in New Brunswick, New Jersey. Dr. Hu is rated as a Distinguished provider by MediFind in the treatment of Alzheimer's Disease. His top areas of expertise are Dementia, Alzheimer's Disease, Primary Lateral Sclerosis, Frontotemporal Dementia, and Hormone Replacement Therapy (HRT). Dr. Hu is currently accepting new patients.

Distinguished in Alzheimer's Disease
Dr. Igor Gefter
Psychiatry
Distinguished in Alzheimer's Disease
Dr. Igor Gefter
Psychiatry

Wayne Behavioral Service LLC

401 Hamburg Tpke, 
Wayne, NJ 
 (3.2 miles away)
973-790-9222
Languages Spoken:
English, Russian, Ukrainian
See accepted insurances
Accepting New Patients
Offers Telehealth

Igor Gefter is a Psychiatrist in Wayne, New Jersey. Dr. Gefter is rated as an Advanced provider by MediFind in the treatment of Alzheimer's Disease. His top areas of expertise are Alzheimer's Disease, Major Depression, Seasonal Affective Disorder (SAD), and Vascular Dementia. Dr. Gefter is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Joseph's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile